https://www.thebodypro.com/category/providing-quality-hiv-care/tag/news

The Latest

Promo Image

This Week in HIV Research: How Should We Measure Success?

The case for a new measurement of HIV treatment success; PrEP and HIV incidence in Australia; benefits of moderate exercise among older people with HIV; CD4 recovery rates after long-term viral suppression.

Promo Image

This Week in HIV Research: Gender Disparities Among the Formerly Incarcerated

Post-incarceration HIV outcomes worse among women; no drug resistance despite apparent PrEP failure; cost-efficacy of adherence self-management; additional cancers in HIV-positive cancer survivors.

Promo Image

This Week in HIV Research: Food, It Does a Body Good

How food insecurity feeds inflammation; racial disparities in HPV16 prevalence; how HIV meds affect pre-existing neurocognitive impairment; central nervous system inflammation in the setting of HIV treatment success.

This Week in HIV Research: The Duracell Batteries of Antiretroviral Therapy Img

This Week in HIV Research: The Duracell Batteries of Antiretroviral Therapy

Among this week's selection of four studies, we learn about data from a large study exploring the relative durability of first-line antiretroviral regimens stratified by drug class. (Spoiler alert: Older protease inhibitors don't do so well.)

HIV diagnosis

This Week in HIV Research: Repeat Diagnoses Reveal Gaps in Care

Sobering data regarding linkage to HIV care among women in the U.S.; Latinx HIV incidence inequalities; efficacy of hepatitis C treatment among people with HIV; and a call for frequent STI testing among at-risk people with HIV.

This Week in HIV Research: Can Vaginal Microbiome Affect HIV Drug Levels? Img

This Week in HIV Research: Can Vaginal Microbiome Affect HIV Drug Levels?

Among our featured reports this week, we learn about how the vaginal microbiome may affect antiretroviral concentrations in the genital tract, and we look at the potential impact of global supply-chain interruptions on HIV drug resistance.

What Should We Do About Persistent Low-Level Viremia? Img

What Should We Do About Persistent Low-Level Viremia?

"When it comes to persistent low-level viremia in treated HIV patients, there's much agony, gnashing of teeth and confusion," Paul Sax, M.D. writes.

This Week in HIV Research: How to Cut U.S. HIV Incidence by 250,000 in 20 Years Img

This Week in HIV Research: How to Cut U.S. HIV Incidence by 250,000 in 20 Years

Among our four featured reports this week, we learn about the critical intersection between HIV treatment access and reduced HIV incidence in the U.S. -- and about the value of replacing placebos with PrEP in clinical trials on HIV prevention.

This Week in HIV Research: It's Not Too Late to Quit Img

This Week in HIV Research: It's Not Too Late to Quit

Among four noteworthy studies we highlight this week is a new addition to the vast mountain of evidence tying lung cancer risk to smoking -- but with an HIV-specific twist, and a caldera of hope for those who quit.

This Week in HIV Research: 'Massive Loss of Life' Img

This Week in HIV Research: 'Massive Loss of Life'

Among this week's collection of four study summaries are data indicating that reducing U.S. foreign aid for HIV-fighting efforts is a really bad idea, no matter which way you cut it.